Abstract
AIMS: To clarify the influence of renal function on adverse outcomes in patients with non-valvular atrial fibrillation (NVAF), a post hoc analysis of the J-RHYTHM Registry was performed. METHODS AND RESULTS: A consecutive series of outpatients with atrial fibrillation (AF) were enrolled from 158 institutions and followed for 2 years or until the occurrence of an event. Among 7406 patients with non-valvular AF, 6052 patients (69.8 ± 10.0 years, 71.2% men) with creatinine clearance (CrCl) value at baseline were divided into four groups according to CrCl level (<30, 30-49.9, 50-79.9, and ≥80 mL/min). Patients with CrCl <80 mL/min showed increased incidence of thromboembolism, major haemorrhage, all-cause and cardiovascular death, and composite events as compared with patients with CrCl ≥80 mL/min. After adjustment for multiple confounders, lower CrCl values emerged as independent predictors for thromboembolism [CrCl 30-49.9, hazard ratio (HR) 2.27, 95% confidence interval (CI) 1.09-4.72, P = 0.029; and CrCl 50-79.9, HR 1.99, 95% CI 1.07-3.72, P = 0.030] and all-cause death (CrCl <30, HR 6.44, 95% CI 3.03-13.7, P < 0.001; and CrCl 30-49.9, HR 3.14, 95% CI 1.54-6.41, P = 0.002), with CrCl ≥80 mL/min serving as a reference, whereas not for major haemorrhage. Warfarin treatment was associated with lower rates of composite events in patients with lower CrCl values of <80 mL/min. CONCLUSION: Renal impairment was an independent predictor of adverse clinical outcomes except for major haemorrhage in Japanese patients with non-valvular AF. Warfarin was associated with lower rates of composite events in patients with lower CrCl values. CLINICAL TRIAL REGISTRATION: http://www.umin.ac.jp/ctr/. Unique identifier: UMIN000001569.